CTOs on the Move

Burdette Medical

www.burdettemedical.com

 
Burdette Medical is a Saint Louis, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Actavis, Inc

The new Actavis, Inc. (NYSE:ACT) is a combination of the previously separate Watson Pharmaceuticals, Inc. and Swiss-based Actavis Group. Actavis, Inc. is a specialty pharmaceutical company that develops, manufactures and distributes generic, brand and biosimilar products. The Company has global headquarters in Parsippany, NJ and international headquarters in Zug, Switzerland.

Auburn Nursing Home

Auburn Nursing Home was founded in 1963 by Frank L. DeFurio, M.D. and Charles B. Richards, M.D. in response to a community need for long term care beds. Auburn Nursing Home opened it doors to the Community on December 1, 1964. Auburn Nursing Home still

Maven Clinic

Maven is the largest virtual clinic for women`s and family health, offering continuous, holistic care for fertility, pregnancy, and parenting. Maven`s award-winning digital programs are trusted by leading employers and health plans to reduce costs and drive better health outcomes for both parents and children. Founded in 2014 by CEO Kate Ryder, Maven has been recognized as Fast Company`s #1 Most Innovative Health Company and has supported more than 10 million women and families to date. Maven has raised $92 million in funding from leading investors including Sequoia, Oak HC/FT, and Female Founders Fund.

LifeCenter Northwest

LifeCenter Northwest is a Bellevue, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acucela

Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.